Literature DB >> 11966873

Effect of Helicobacter pylori-induced cyclooxygenase-2 on gastric epithelial cell kinetics: implication for gastric carcinogenesis.

Casmir Wambura1, Nobuo Aoyama, Daisuke Shirasaka, Toshiyuki Sakai, Takahiro Ikemura, Masanori Sakashita, Shuji Maekawa, Kohei Kuroda, Takashi Inoue, Shigeyuki Ebara, Masaki Miyamoto, Masato Kasuga.   

Abstract

BACKGROUND: Cyclooxygenase (COX)-2 induced by Helicobacter pylori is thought to enhance gastric carcinogenesis by affecting the maintenance of epithelial homeostasis.
MATERIALS AND METHODS: Gastric biopsies from 160 subjects, 97 with nonulcer dyspepsia (47 H. pylori negative, 50 H. pylori positive) and 63 with gastric cancer were examined immunohistochemically for COX-2 expression, cell proliferation and apoptotic indices.
RESULTS: COX-2 expression in corpus was significantly higher in H. pylori positive than in negative non-ulcer dyspepsia (NUD) (p <.05). Regardless of site, gastric cancer subjects had higher COX-2 expression in both antrum and corpus compared with H. pylori negative and positive NUD (p <.005). Proliferation was higher in cancer and H. pylori positive than in negative NUD (p <.0001). Moreover, cancer had enhanced proliferation than H. pylori positive NUD in corpus greater (p =.0454) and antrum lesser (p =.0215) curvatures. Apoptosis was higher in H. pylori positive than in negative NUD (p <.05). However, both had a higher index than the cancer subjects (p <.0001). Apoptosis : proliferation ratio was higher in corpus of H. pylori negative than in positive NUD in greater (p =.0122) and lesser (p =.0009) curvatures. However, both had a higher A:P ratio than cancer cases (p =.0001). A negative correlation between COX-2 expression and A:P ratio was found in corpus greater (r = -.176, p =.0437) and lesser (r = -.188, p =.0312) curvatures.
CONCLUSION: The expression of COX-2 is associated with disruption in gastric epithelial kinetics and hence may play a role in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966873     DOI: 10.1046/j.1083-4389.2002.00069.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  7 in total

1.  Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions.

Authors:  Asahi Hishida; Keitaro Matsuo; Yasuyuki Goto; Nobuyuki Hamajima
Journal:  World J Gastrointest Oncol       Date:  2010-10-15

Review 2.  Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.

Authors:  Yun Dai; Wei-Hong Wang
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

3.  Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells.

Authors:  Junzo Hisatsune; Eiki Yamasaki; Masaaki Nakayama; Daisuke Shirasaka; Hisao Kurazono; Yohtaro Katagata; Hiroyasu Inoue; Jiahuai Han; Jan Sap; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

4.  Expression of COX-2 proteins in gastric mucosal lesions.

Authors:  Lian-Zhen Yu; Heng-Jun Gao; Jian-Feng Bai; Gu Sun; Han-Lin Zhao; Liang Sun; Kun Miu; Zhi-Quan Zhao
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

5.  The role of COX-2 in rectal cancer treated with preoperative radiotherapy.

Authors:  Hanifa Bouzourene; Pu Yan; Dominique Sandmeier; Abderrahim Zouhair; Maurice Matter; Henri Vuilleumier; Philippe Coucke
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

6.  Assessment of Helicobacter pylori eradication in patients on NSAID treatment.

Authors:  Harald E Vonkeman; Htji Deleest; Mafj van Delaar; J Vanbaarlen; Kss Steen; Wf Lems; Jwj Bijlsma; Ej Kuipers; Hhml Houben; M Janssen; Bac Dijkmans
Journal:  BMC Gastroenterol       Date:  2012-09-24       Impact factor: 3.067

7.  Quantitative analysis of COX-2 promoter methylation in gastric carcinoma.

Authors:  Ho Goon Kim; Seong Yeob Ryu; Kyung Hwa Lee; Jae Hyuk Lee; Dong Yi Kim
Journal:  Ann Surg Treat Res       Date:  2018-07-30       Impact factor: 1.859

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.